Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

Christopher Skedgel, Daniel Rayson, Tallal Younis

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
12 Downloads (Pure)
Original languageEnglish
Pages (from-to)387-394
Number of pages8
JournalJournal of Supportive Care in Cancer
Issue number1
Early online date17 Jun 2015
Publication statusPublished - Jan 2016

Cite this